JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.32, sa.7, ss.781-783, 2019 (SCI-Expanded)
Background: The clinical phenotypes of carnitine palmitoyltransferase type-2 deficiency (CPT2D) are classified into lethal neonatal, severe infantile and muscle forms. The rarest form is the lethal neonatal form.